Quality of life after CAR-T or stem cell transplant
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study looks at how patients feel after receiving CAR-T therapy or a stem cell transplant for blood cancers. Your answers to a questionnaire will help doctors understand your experience and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer like leukemia, lymphoma, or multiple myeloma.
- You are scheduled to receive or have received CAR-T therapy or a stem cell transplant.
- You are able to understand and complete a questionnaire in Italian.
- You can give written consent to participate.
- You are not too ill to complete the questionnaire (life expectancy more than 7 days).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a coping skills training program to help people who have had a stem cell transplant or CAR-T cell therapy for blood cancer manage fatigue, pain, and stress. It may help you feel better and be more active in daily life.
This study uses brain scans and blood markers to understand how CAR T-cell therapy affects the brain. It may help researchers predict or manage potential side effects.
This study looks at quality of life and how medicines are used for people who are getting CAR-T cell therapy for DLBCL. It aims to better understand what helps patients feel and function during follow-up after treatment.
This study looks at how patients with blood cancers are managed in real life when they receive CAR-T cell therapy. It helps doctors learn more about how well these treatments work outside of clinical trials.
This study looks at tissue samples from adults who are receiving CAR-T cell therapy for blood-related conditions. It aims to learn more about how CAR-T works and what changes happen in the body, which may help improve future care.
This study looks at how people with blood cancers do after they receive CAR-T therapy, radiation therapy, and/or bispecific therapy. It may help doctors understand which treatment combinations work best and what side effects to expect.
Hear when a new Patient Reported Outcome (PRO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.